Outcomes for<unk>  are generally very poor, with fewer than 10% of patients surviving more than 5 years. Without treatment, few patients survive more than 6 months.
Amyloid cardiomyopathy
Cardiac amyloidosis
Alcoholic cardiomyopathy
Viral cardiomyopathy
Phidippides cardiomyopathy
Diabetic cardiomyopathy
Dilated cardiomyopathy
Noncompaction cardiomyopathy